A new lawsuit filed by Hamilton County accuses multiple drug manufacturers and pharmacy benefit managers of inflating the ...

Advertising a drug’s name and a use that is off-label is “a double whammy,” said Patrick Massad, commissioner of the Pharmaceutical Advertising Advisory Board (PAAB), an organization that is ...

Dinn has been quick to call out the current government on their lack of transparency — despite the new PC government’s claims that they are — on a few occasions. He cites the pharmacare call coming ...

The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but recent challenges have centered around ...

Feb 12 (Reuters) - West Pharmaceutical forecast annual profit above Wall Street estimates on Thursday, banking on higher demand for diabetes and obesity treatments that use its medical equipment. The ...

Senior Manager of Policy with Diabetes Canada, Laura O’Driscoll of Grand Falls-Windsor says when it comes to chronic illness like diabetes, an ounce of prevention is worth a pound of cure, and timely ...

Diabetes drugs that may soon be prescribed more widely in England could save thousands of lives each year, suggests a new ...

Novo's lawsuit comes less than one week after Hims & Hers announced plans to sell a compounded version of Novo's weight-loss ...

An experimental combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to late-stage trial ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

Whether you’ve been managing type 2 diabetes for months or years, one thing is probably true: You want the most up-to-date information on how to manage the condition. One of the best ways to do that ...